Approval · Notice of Compliance 17787 · 2016
VERDESO: Notice of Compliance 17787
Issued February 12, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17787
- Date
- February 12, 2016
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of an alternate drug substance manufacturing and testing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VERDESO | Not yet assigned | — |
Medicinal ingredients
- DESONIDE 0.05 PER